
																
																	EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib
																
																
																
															Keywords: L792H; G796R; Osimertinib; EGFR TKIs; Acquired drug-resistance;